Neurocrine Biosciences Reports First Quarter 2022 Financial Results and Reiterates 2022 Financial Guidance
Go back to Neurocrine Biosciences Reports First Quarter 2022 Financial Results and Reiterates 2022 Financial Guidance| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 175.77 -1.72 (0.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $177.49 | 52 Week High | $58.46 | |||
| Open | $177.70 | 52 Week Low | $31.25 | |||
| Day High | $178.56 | P/E | N/A | |||
| Day Low | $175.77 | EPS | $-0.69 | |||
| Volume | 337,074 | |||||
